« That's Where The Money Is |
| Sulfolane »
November 16, 2012
Part Eleven? Really?
And here's another item, sent in by a reader, who noted this publication in Bioorganic and Medicinal Chemistry Letters. I have no problem with the work at all, and certainly no problem with the people who did it (some of whom I know), but Part Eleven? I'm trying to figure out why this would be sliced quite so thinly - the only thing that comes to mind is to scatter a wide group of co-authors across several publications, so as to give everyone something on their CV. But how much does a multipart BOMCL count for - heck, while we're on the subject, how much does most any publication count for in today's hiring environment? Update: note that this is not one of those multiyear series things - most of these appear to be in press right now.
+ TrackBacks (0) | Category: The Scientific Literature
POST A COMMENT
- RELATED ENTRIES
- Amicus Fights Its Way Through in Fabry's
- Did Pfizer Cut Back Some of Its Best Compounds?
- Don't Optimize Your Plasma Protein Binding
- Fluorinated Fingerprinting
- One of Those Days
- ChemDraw Days
- Incomprehensible Drug Prices? Think Again.
- Proteins Grazing Against Proteins